HLS Therapeutics Inc (TSE:HLS) has released an update.
HLS Therapeutics Inc., a company specializing in psychiatric and cardiovascular treatments, will present at the upcoming H.C. Wainwright’s 26th Annual Global Investment Conference on September 11, 2024. Their CEO, Craig Millian, will not only present but also engage in one-on-one meetings with investors at the New York City event. The presentation will be accessible via webcast and later archived on the company’s website for 90 days.
For further insights into TSE:HLS stock, check out TipRanks’ Stock Analysis page.
